Low-density lipoprotein cholesterol and risk of COPD: Copenhagen General Population Study

Low-density lipoprotein cholesterol and risk of COPD: Copenhagen General Population Study

Background Randomised controlled trials found that low-density lipoprotein (LDL) cholesterol-lowering statins increase lung function and possibly decrease rate of exacerbations in individuals with COPD. However, it is unknown whether high levels of LDL cholesterol are associated with increased susce...

Full description

Bibliographic Details
Main Authors: Josefine Freyberg, Eskild M. Landt, Shoaib Afzal, Børge G. Nordestgaard, Morten Dahl
Format: Article
Language:English
Published: European Respiratory Society 2023-03-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/9/2/00496-2022.full

Internet

http://openres.ersjournals.com/content/9/2/00496-2022.full

Similar Items